Nifty
Sensex
:
:
12968.95
44149.72
-18.05 (-0.14%)
-110.02 (-0.25%)

Pharmaceuticals & Drugs - Global

Rating :
71/99

BSE: 500420 | NSE: TORNTPHARM

2615.10
27-Nov-2020
  • Open
  • High
  • Low
  • Previous Close
  •  2620.00
  •  2679.50
  •  2596.00
  •  2615.70
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  661988
  •  17433.82
  •  3031.20
  •  1583.25

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 44,182.09
  • 36.94
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 49,355.47
  • 1.23%
  • 7.99

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 71.25%
  • 0.59%
  • 7.12%
  • FII
  • DII
  • Others
  • 12.17%
  • 8.14%
  • 0.73%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.71
  • 3.49
  • 10.09

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 18.79
  • -4.48
  • 9.97

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.26
  • -9.98
  • 14.75

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 22.04
  • 35.50
  • 42.36

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 6.13
  • 6.19
  • 6.38

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 14.12
  • 15.65
  • 17.95

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Net Sales
2,017.00
2,005.00
0.60%
2,056.00
2,022.00
1.68%
1,946.00
1,856.00
4.85%
1,966.00
2,051.00
-4.14%
Expenses
1,382.00
1,464.00
-5.60%
1,395.00
1,481.00
-5.81%
1,398.00
1,383.00
1.08%
1,426.00
1,490.00
-4.30%
EBITDA
635.00
541.00
17.38%
661.00
541.00
22.18%
548.00
473.00
15.86%
540.00
561.00
-3.74%
EBIDTM
31.48%
26.98%
3.55%
3.55%
14.01%
14.01%
27.47%
27.35%
Other Income
6.00
34.00
-82.35%
4.00
20.00
-80.00%
15.00
17.00
-11.76%
53.00
3.00
1,666.67%
Interest
92.00
116.00
-20.69%
102.00
122.00
-16.39%
102.00
123.00
-17.07%
111.00
133.00
-16.54%
Depreciation
165.00
163.00
1.23%
161.00
160.00
0.62%
168.00
160.00
5.00%
163.00
156.00
4.49%
PBT
384.00
296.00
29.73%
15.41
15.41
0.00%
293.00
-150.00
-
319.00
275.00
16.00%
Tax
74.00
52.00
42.31%
1.10
1.10
0.00%
-21.00
2.00
-
68.00
29.00
134.48%
PAT
310.00
244.00
27.05%
14.31
14.31
0.00%
314.00
-152.00
-
251.00
246.00
2.03%
PATM
15.37%
12.17%
37.11%
37.11%
7.11%
7.11%
12.77%
11.99%
EPS
18.32
14.42
27.05%
0.85
0.85
0.00%
18.56
-8.98
-
14.83
14.54
1.99%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
7,985.00
7,939.31
7,672.80
5,949.83
5,815.69
6,686.93
4,653.45
4,184.72
3,211.14
2,695.92
2,197.79
Net Sales Growth
0.64%
3.47%
28.96%
2.31%
-13.03%
43.70%
11.20%
30.32%
19.11%
22.67%
 
Cost Of Goods Sold
5,762.36
1,981.79
2,041.26
1,535.17
1,629.66
1,452.21
1,280.96
1,107.58
807.98
774.38
616.64
Gross Profit
2,222.64
5,957.52
5,631.54
4,414.66
4,186.03
5,234.72
3,372.49
3,077.14
2,403.16
1,921.54
1,581.16
GP Margin
27.84%
75.04%
73.40%
74.20%
71.98%
78.28%
72.47%
73.53%
74.84%
71.28%
71.94%
Total Expenditure
5,601.00
5,768.95
5,696.31
4,600.58
4,438.42
3,957.13
3,633.29
3,233.24
2,518.92
2,203.54
1,810.01
Power & Fuel Cost
-
128.19
132.46
118.77
107.98
92.59
97.41
71.88
62.80
56.97
42.53
% Of Sales
-
1.61%
1.73%
2.00%
1.86%
1.38%
2.09%
1.72%
1.96%
2.11%
1.94%
Employee Cost
-
1,429.04
1,403.79
1,135.25
993.41
842.35
841.81
741.10
623.29
531.80
440.44
% Of Sales
-
18.00%
18.30%
19.08%
17.08%
12.60%
18.09%
17.71%
19.41%
19.73%
20.04%
Manufacturing Exp.
-
544.11
558.84
457.58
502.16
353.45
345.98
320.78
278.15
225.27
210.89
% Of Sales
-
6.85%
7.28%
7.69%
8.63%
5.29%
7.43%
7.67%
8.66%
8.36%
9.60%
General & Admin Exp.
-
801.98
763.90
677.71
578.05
637.92
477.59
399.07
324.55
255.89
206.88
% Of Sales
-
10.10%
9.96%
11.39%
9.94%
9.54%
10.26%
9.54%
10.11%
9.49%
9.41%
Selling & Distn. Exp.
-
807.39
738.03
641.30
567.70
547.05
574.40
461.53
393.07
322.29
274.61
% Of Sales
-
10.17%
9.62%
10.78%
9.76%
8.18%
12.34%
11.03%
12.24%
11.95%
12.49%
Miscellaneous Exp.
-
76.45
58.03
34.80
59.46
31.56
15.14
131.30
29.08
36.94
274.61
% Of Sales
-
0.96%
0.76%
0.58%
1.02%
0.47%
0.33%
3.14%
0.91%
1.37%
0.82%
EBITDA
2,384.00
2,170.36
1,976.49
1,349.25
1,377.27
2,729.80
1,020.16
951.48
692.22
492.38
387.78
EBITDA Margin
29.86%
27.34%
25.76%
22.68%
23.68%
40.82%
21.92%
22.74%
21.56%
18.26%
17.64%
Other Income
78.00
121.30
63.62
298.84
223.30
228.80
285.55
38.13
43.36
52.78
56.23
Interest
407.00
450.71
503.75
308.48
205.56
183.98
175.16
58.63
33.80
39.45
39.13
Depreciation
657.00
654.38
617.69
408.60
306.92
237.55
190.74
87.00
82.69
81.73
62.56
PBT
1,011.41
1,186.57
918.67
931.01
1,088.09
2,537.07
939.81
843.98
619.09
423.98
342.33
Tax
122.10
161.85
125.35
252.87
154.51
610.17
188.84
180.07
146.69
72.32
72.17
Tax Rate
12.07%
13.64%
22.32%
27.16%
14.20%
26.04%
20.09%
21.34%
25.22%
20.17%
21.08%
PAT
889.31
1,024.72
436.28
678.11
933.55
1,733.24
750.94
663.88
432.76
284.04
270.17
PAT before Minority Interest
889.31
1,024.72
436.31
678.14
933.58
1,733.27
750.97
663.91
434.91
286.30
270.17
Minority Interest
0.00
0.00
-0.03
-0.03
-0.03
-0.03
-0.03
-0.03
-2.15
-2.26
0.00
PAT Margin
11.14%
12.91%
5.69%
11.40%
16.05%
25.92%
16.14%
15.86%
13.48%
10.54%
12.29%
PAT Growth
152.42%
134.88%
-35.66%
-27.36%
-46.14%
130.81%
13.11%
53.41%
52.36%
5.13%
 
EPS
52.56
60.56
25.78
40.08
55.17
102.44
44.38
39.24
25.58
16.79
15.97

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
4,823.22
4,724.35
4,622.19
4,350.13
3,494.10
2,490.56
1,902.43
1,421.93
1,193.83
1,022.40
Share Capital
84.62
84.62
84.62
84.62
84.62
84.62
84.62
42.31
42.31
42.31
Total Reserves
4,738.60
4,639.73
4,537.57
4,265.51
3,409.48
2,405.94
1,817.81
1,379.62
1,151.52
980.10
Non-Current Liabilities
3,299.15
3,861.40
4,142.42
2,303.33
1,994.65
2,504.92
926.76
619.81
487.73
397.60
Secured Loans
3,302.29
3,909.81
4,105.31
2,229.57
1,839.46
2,171.60
730.72
403.19
223.83
170.59
Unsecured Loans
1.56
3.11
6.15
11.26
10.62
13.62
13.74
51.35
98.22
122.45
Long Term Provisions
338.34
288.52
286.66
263.04
246.36
207.49
190.43
129.51
110.45
56.14
Current Liabilities
5,482.21
5,165.32
5,202.17
2,738.26
3,285.48
2,823.75
2,174.58
1,710.65
1,362.84
1,114.09
Trade Payables
2,076.86
2,096.74
2,048.24
1,749.32
2,260.22
1,827.72
1,429.13
1,067.74
863.47
615.00
Other Current Liabilities
1,860.80
1,641.26
1,151.68
687.14
822.28
446.15
371.63
275.83
291.00
312.85
Short Term Borrowings
1,090.85
934.11
1,625.60
0.00
3.32
319.07
210.43
124.62
138.12
99.57
Short Term Provisions
453.70
493.21
376.65
301.80
199.66
230.81
163.39
242.46
70.25
86.66
Total Liabilities
13,604.58
13,751.07
13,967.30
9,392.21
8,774.69
7,819.66
5,004.17
3,752.76
3,047.90
2,535.69
Net Block
7,533.12
7,747.71
7,854.68
3,688.44
2,859.08
2,832.66
875.34
819.82
796.87
635.55
Gross Block
10,334.13
9,935.43
9,449.48
4,909.80
3,793.53
3,542.93
1,420.04
1,278.15
1,199.64
964.28
Accumulated Depreciation
2,801.01
2,187.72
1,594.80
1,221.36
934.45
710.27
544.70
458.33
402.77
328.73
Non Current Assets
8,595.61
8,713.53
8,704.89
4,512.74
4,085.66
3,768.25
1,599.69
1,191.87
1,060.78
941.27
Capital Work in Progress
711.93
617.12
646.94
519.49
1,041.58
678.33
534.11
285.28
113.55
179.88
Non Current Investment
2.09
2.09
0.09
0.09
0.09
0.06
0.03
0.03
37.52
20.00
Long Term Loans & Adv.
222.19
150.58
130.96
182.32
99.66
206.92
129.47
62.84
61.37
59.51
Other Non Current Assets
126.28
196.03
72.22
122.40
85.25
50.28
60.74
23.90
46.25
46.34
Current Assets
5,008.97
5,037.54
5,262.41
4,879.47
4,689.03
4,051.41
3,404.48
2,560.89
1,987.12
1,594.42
Current Investments
0.02
351.35
492.27
803.55
779.59
297.59
185.63
60.44
86.52
125.99
Inventories
2,148.22
1,935.15
1,966.30
1,559.15
1,357.98
1,067.17
1,006.06
923.86
531.56
504.83
Sundry Debtors
1,649.34
1,435.71
1,253.45
950.89
1,445.09
1,587.26
1,099.42
687.82
522.80
340.40
Cash & Bank
666.65
816.04
867.23
893.72
647.03
567.36
769.42
626.97
674.28
478.80
Other Current Assets
544.74
405.83
587.77
589.54
459.34
532.03
343.95
261.80
171.96
144.41
Short Term Loans & Adv.
101.53
93.46
95.39
82.62
90.18
109.09
84.95
75.95
56.46
49.28
Net Current Assets
-473.24
-127.78
60.24
2,141.21
1,403.55
1,227.66
1,229.90
850.24
624.28
480.33
Total Assets
13,604.58
13,751.07
13,967.30
9,392.21
8,774.69
7,819.66
5,004.17
3,752.76
3,047.90
2,535.69

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
1,391.79
1,798.08
894.15
1,008.84
2,742.12
810.20
599.42
153.48
499.13
395.01
PBT
1,186.57
561.66
931.01
1,088.09
2,343.44
939.81
843.98
581.60
358.62
342.33
Adjustment
875.09
1,418.19
606.92
430.27
552.44
337.96
136.79
126.13
79.64
74.80
Changes in Working Capital
-385.83
99.39
-360.16
-125.21
423.58
-409.38
-119.68
-421.75
143.58
61.88
Cash after chg. in Working capital
1,675.83
2,079.24
1,177.77
1,393.15
3,319.46
868.39
861.09
285.98
581.84
479.01
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-284.04
-281.16
-283.62
-384.31
-577.34
-58.19
-261.67
-132.50
-82.71
-84.00
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-151.57
-241.28
-4,706.95
-786.91
-837.85
-2,162.30
-355.81
-241.70
-136.97
-232.60
Net Fixed Assets
-378.80
-610.74
-4,245.22
-592.01
-471.42
-2,266.57
-308.01
-455.28
-84.67
-52.13
Net Investments
351.33
138.83
310.79
-17.69
-484.32
-111.97
-131.60
287.55
-47.29
-199.04
Others
-124.10
230.63
-772.52
-177.21
117.89
216.24
83.80
-73.97
-5.01
18.57
Cash from Financing Activity
-1,549.04
-1,314.45
3,417.39
-192.91
-1,435.15
1,212.25
86.40
19.73
-192.74
-67.61
Net Cash Inflow / Outflow
-308.82
242.35
-395.41
29.02
469.12
-139.85
330.01
-68.49
169.42
94.80
Opening Cash & Equivalents
940.06
702.04
1,067.57
1,049.86
612.38
955.05
687.41
760.80
604.79
510.45
Closing Cash & Equivalent
661.82
940.06
702.04
1,067.57
1,049.86
864.95
955.05
687.41
760.80
604.79

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
284.99
279.15
273.11
257.04
206.46
147.16
112.41
84.02
70.54
60.42
ROA
7.49%
3.15%
5.81%
10.28%
20.89%
11.71%
15.16%
12.79%
10.26%
12.04%
ROE
21.47%
9.34%
15.12%
23.80%
57.92%
34.19%
39.94%
33.25%
25.84%
29.15%
ROCE
15.28%
9.75%
13.81%
20.36%
45.63%
26.98%
35.06%
31.66%
23.65%
25.88%
Fixed Asset Turnover
1.48
1.50
1.57
1.35
1.82
1.88
3.11
2.60
2.50
2.48
Receivable days
37.65
33.78
35.74
74.66
82.76
105.19
77.81
68.65
58.33
52.95
Inventory Days
49.84
49.01
57.16
90.90
66.19
81.17
84.02
82.53
70.03
68.69
Payable days
134.37
139.05
150.99
171.27
204.35
176.11
158.58
143.69
136.22
103.96
Cash Conversion Cycle
-46.89
-56.26
-58.09
-5.72
-55.41
10.25
3.25
7.50
-7.86
17.68
Total Debt/Equity
1.21
1.28
1.40
0.58
0.67
1.10
0.59
0.49
0.48
0.56
Interest Cover
3.63
2.11
4.02
6.29
13.74
6.37
15.40
18.21
10.09
9.75

News Update:


  • Torrent Pharmaceuticals reports 27% rise in Q2 consolidated net profit
    27th Oct 2020, 11:28 AM

    Total income of the company decreased by 0.78% at Rs 2023 crore for Q2FY21

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.